What are the payment terms?

The standard term of payment is T/T (Telegraphic Transfer).

Where is the supplier located and what are the main markets?

Located in Foshan, Guangdong, China, with main markets in East Asia, Australia, and domestic regions.

Philodendron Gloriosum Tissue Culture Invitro Stage 3 Plants

Name: Philodendron Gloriosum Tissue Culture Invitro Stage 3 Plants
Brand: Foshan Sanshui Youngplants Co., Ltd.
SKU: 1975041395

Guangdong, ChinaFoshan Sanshui Youngplants Co., Ltd.

Negotiable

100 Pieces

Product profile

Customization

Available

Growth Environment

Subtropical

Watch Parts

Leaf

Model NO.

Philodendron

Scent

Odorless

Application

Indoor

Type

Invitro

Transportation

by Air

Transport Package

Carton/Foam

Specification

Trademark

YoungPlants

Origin

Foshan

HS Code

0602909199

Production Capacity

400000

Key features

Indoor Application: Ideal for indoor settings, featuring green foliage and an odorless nature.

Invitro Stage 3: High-quality tissue culture plants at the Invitro Stage 3 for robust growth.

Customized Transport: Transportation can be customized by air to ensure safe delivery.

Established Manufacturer: Produced by a factory established in 2008 with 30,000 sqm plant area.

ODM & OEM Service: Offers both ODM and OEM services with dedicated R&D engineers.

Fast Lead Time: Average lead time is one month for both peak and off-season periods.

Global Export: Exports to East Asia, Australia, and domestic markets via FOB/CIF terms.

Company profile

Foshan Sanshui Youngplants Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2008-08-31 CertifiedNearest Port: Foshan Port, Shenzhen PortAverage Response Time: ≤6.41hTerms of Payment: T/T

AI-Powered supplier vetting

SummaryFoshan Youngplants is a China-based limited company and factory specializing in tissue culture plants. It was established in 2008, began exporting in 2008, and reports that 71%–90% of sales come from exports. The supplier identifies 30,000 m² of manufacturing area, six in vitro laboratories covering more than 9,000 m², ten production lines, and 50 quality-control staff. It reports over 80 million annual output and serves markets including Japan, South Korea, Australia, and domestic customers. Evidence also indicates AEO, high-technology, nursery, and model laboratory honors, although certification details and validity are not provided. The supplier’s innovation, customization, after-sales, financial credibility, and customer-case strength cannot be fully verified from the supplied information.

Supplier typeThe supplier is identified as a limited company, factory, and combined business entity operating in Foshan, Guangdong, China. Its stated agricultural and biotechnology focus, together with tissue-culture production facilities, supports classification as a manufacturing supplier rather than only a trading intermediary.

CertificationsThe supplier states that it has received an Authorized Economic Operator (AEO) Certificate and honors including “One of The Best Nurseries,” “Model Tissue Culture Lab,” and “High Technology Expertise.” However, the slices do not provide certificate numbers, issuing dates, scope, or current validity.

R&D capabilityThe supplier specializes in in vitro tissue culture, operates six laboratories, reports more than 70 technologists and management personnel in one company description, and highlights innovation and new-cultivar cooperation. It also states that it has received high-technology recognition, providing positive evidence of technical capability, although R&D staffing information is inconsistent across slices and specific innovations are not documented.

Production capacityProduction evidence includes a stated annual output exceeding 80 million, a 30,000 m² manufacturing plant, six tissue-culture laboratories covering more than 9,000 m², ten production lines, and 50 quality-control staff. The supplier also reports one-month order fulfillment in both peak and off-peak seasons, indicating substantial stated capacity, although the output figure is presented in a company description without product-unit clarification.